The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing
Crossref DOI link: https://doi.org/10.1186/s13046-021-02139-7
Published Online: 2021-10-26
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tao, Mengyu
Wu, Xia
Text and Data Mining valid from 2021-10-26
Version of Record valid from 2021-10-26
Article History
Received: 6 May 2021
Accepted: 12 October 2021
First Online: 26 October 2021
Declarations
:
: Not applicable.